Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

biotech-medical-pills
The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Health Care ETFs In Focus As House Votes To Repeal Obamacare

healthcare
From Brad Hoppmann: Republicans in the House of Representatives finally cobbled together enough "yes" votes to do what they’ve been promising to do for some seven years … repeal and replace the "Affordable Care Act" (ACA), aka Obamacare.
NYSE:XLV May 5, 2017 7:14am

BlackRock: Health Care Sector Looks Attractive Amid Global Risks

Medical Device
From BlackRock: With risks abounding in the markets, Russ Koesterich discusses the case for health care as a defensive sector.
NYSE:IYH May 4, 2017 4:13pm

IHI: Keep Riding The Medical Devices Momentum

Medical Device
Momentum traders have no doubt had the healthcare equipment sector on their radar, and maybe even for some time. While the healthcare and biotech sectors were posting losses in 2016, the medical devices sector bucked the trend with the iShares U.S. Medical Devices ETF (IHI) returning more than 9%.
NYSE:IHI April 24, 2017 8:31am

Will Biotech Bulls Or Bears Blink First?

leverage bull bear 600X300
From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.
NASDAQ:IBB April 21, 2017 6:21am

New Month Brings Fresh Outflows In Small Cap Funds Once Again

smallcap
Analyst Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today picks up on renewed selling of small cap funds, along with some apparent sector rotation into energy and away from a few other sectors.
NYSE:IWM April 5, 2017 12:40pm

BlackRock: Opportunities Abound In Biotech, Healthcare

biotech-white-pills
From BlackRock: A dynamic of haves versus have-nots means that health care is increasingly all about stock picking. Kate Moore sees opportunities in biotech, medical devices, U.S. managed care and selected big pharma with promising drug pipelines.
NASDAQ:IBB April 3, 2017 7:26am

This Tiny Early-Stage Biotech ETF Was Q1’s Best Performing Fund

biotech-dna
From Zacks: After being stressed by the twin attacks of higher drug pricing and increased regulatory scrutiny, the biotech sector has made a strong comeback in the first quarter of 2017.
NASDAQ:BBC March 31, 2017 9:38am

Why You Should Be Avoiding Healthcare Service Stocks Right Now

Medical Device
With a relatively light economic calendar this week, the President’s Obamacare replacement bill (the American Health Care Act if you want to use its formal name, Trumpcare if you don’t) takes center stage as the House is tentatively scheduled to vote on it on Thursday.
NYSE:XHS March 20, 2017 12:55pm

Here Are The Best Performing ETFs Of 2017 Thus Far

momentum-up
From Moby Waller: A huge amount of money goes into passive stock market tracking these days, through the S&P 500 Index (SPY) and other major U.S. indexes (DIA) (QQQ) (IWM). This strategy has done well in general in recent years and has gained popularity, particularly in retirement-type accounts.
NYSE:XBI March 17, 2017 6:21am

Time To Buy Pharmaceutical ETFs?

Image of multicolor pills in blister pack
From Zacks: 2016 turned out to be a challenging year for pharma stocks with the sector facing a lot of criticism for rising drug prices. Although the election results provided a breather for the sector on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the relief rally turned out to be short-lived with the President clarifying his stand on rising drug prices.
NYSE:PJP March 16, 2017 7:32am

Healthcare ETFs Find Renewed Bull Market Amid Trump Tax Reform Promises

pills healthcare
We've profiled the Healthcare space in terms of relevant ETFs in the sector on several occasions since Trump’s election last year, because it quite simply has been much more volatile than its historical norms.
NYSE:XLV March 15, 2017 12:30pm

Have Biotech ETFs Finally Bottomed?

biotech-white-pills
From Zacks: 2016 was a tough year for biotech stocks with the sector facing a lot of criticism for rising drug prices. Although shares did rally post-election in November on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the rally turned out to be short-lived following the President’s views regarding drug pricing.
NASDAQ:IBB March 14, 2017 7:54am

These Indexes Are The Best Indicators For A Potential Bear Market Developing

bear-1397235-640x480
From Taki Tsaklanos: Global stock markets remain strong. The leading U.S. stock market indexes keep on moving near all-time highs. European stock market indexes refuse to go lower, and emerging stock markets touched multi-year highs very recently.
NYSE:XLV March 13, 2017 6:08am

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories